Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhFGF-2 in Miller's Class I and II Gingival Recession
NCT04361630Phase 1Completed
- Sponsor
- SVS Institute of Dental Sciences
- Start
- May 2019
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of trafermin in gingival recession, sponsored by SVS Institute of Dental Sciences. Primary endpoint: Width of keratinized gingiva at 5 months. Started May 2019; status: completed.
02
Drugs
trafermin
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT04361630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361630.